文献速递慢性肾脏病遗传性与小管间质肾病肾移植

基因检测在成人慢性肾脏病中的作用

The Role of Genetic Testing in Adult CKD.
PubMed 文献 · J Am Soc Nephrol · 2024-05-06

本文综述指出,单基因病是相当比例慢性肾脏病(CKD)患者的潜在病因,测序技术与数据分析的进步显著提高了基因检测的诊断率。检出致病性变异有助于预后判断、个体化管理、肾移植决策及遗传咨询,并可筛查高危家属与评估供肾资格。尽管已有临床效用与成本效益证据,许多肾内科医生仍未充分利用基因检测,本文据此给出检测对象、项目选择、结果解读及检测前后遗传咨询的建议。

要点

  • 单基因病是相当比例成人CKD的潜在病因,基因检测诊断率随测序技术进步而显著提高。
  • 基因诊断可指导预后判断、肾保护与肾移植决策,并支持遗传咨询与家庭生育规划。
  • 基因诊断有助于筛查高危家属并评估其作为肾移植供者的资格。

核心结论

  • 基因检测对许多成人CKD患者具有显著临床获益,应推动肾内科医生在临床实践中落实应用。

研究设计与样本

  • 综述类文章,基于最新认识并结合患者病例片段进行阐述。

主要发现

  • 单基因病是相当比例CKD患者的潜在病因。
  • 近年测序技术与数据分析的革新使基因检测诊断率显著提高。
  • 识别致病性变异可促进预后判断与个体化管理,包括肾保护与肾移植决策。
  • 基因诊断对遗传咨询与生殖家庭规划至关重要,并支持筛查高危家属及评估其供肾资格。
  • 尽管有临床效用、可及性与成本效益证据,许多肾内科医生因多种感知障碍未充分发挥基因检测作用。

临床怎么用

  • 推动基因检测作为成人CKD的诊断手段之一。
  • 明确应检测的患者人群与应开具的检测项目。
  • 规范基因检测结果的解读。
  • 重视检测前与检测后遗传咨询的必要性及核心组成。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Mounting evidence indicates that monogenic disorders are the underlying cause in a significant proportion of patients with CKD. In recent years, the diagnostic yield of genetic testing in these patients has increased significantly as a result of revolutionary developments in genetic sequencing techniques and sequencing data analysis. Identification of disease-causing genetic variant(s) in patients with CKD may facilitate prognostication and personalized management, including nephroprotection and decisions around kidney transplantation, and is crucial for genetic counseling and reproductive family planning. A genetic diagnosis in a patient with CKD allows for screening of at-risk family members, which is also important for determining their eligibility as kidney transplant donors. Despite evidence for clinical utility, increased availability, and data supporting the cost-effectiveness of genetic testing in CKD, especially when applied early in the diagnostic process, many nephrologists do not use genetic testing to its full potential because of multiple perceived barriers. Our aim in this article was to empower nephrologists to (further) implement genetic testing as a diagnostic means in their clinical practice, on the basis of the most recent insights and exemplified by patient vignettes. We stress why genetic testing is of significant clinical benefit to many patients with CKD, provide recommendations for which patients to test and which test(s) to order, give guidance about interpretation of genetic testing results, and highlight the necessity for and essential components of pretest and post-test genetic counseling.

来源:J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Knoers NVAM, van Eerde AM. The Role of Genetic Testing in Adult CKD. J Am Soc Nephrol. 2024. PMID: 39288914. doi:10.1681/ASN.0000000000000401

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。